Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
Autor: | Venner, Christopher P., Lane, Thirusha, Foard, Darren, Rannigan, Lisa, Gibbs, Simon D.J., Pinney, Jennifer H., Whelan, Carol J., Lachmann, Helen J., Gillmore, Julian D., Hawkins, Philip N., Wechalekar, Ashutosh D. |
---|---|
Zdroj: | In Blood 10 May 2012 119(19):4387-4390 |
Databáze: | ScienceDirect |
Externí odkaz: |